v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
May 31, 2025
May 31, 2024
Cash flows from operating activities    
Net (loss) income $ (64,037) $ 9,111
Adjustments to reconcile net income to net cash provided by operating activities    
Depreciation and amortization 6,857 3,459
Change in fair value of contingent consideration (640) (270)
Discharge of holdback obligation related to Immunetrics acquisition (224) 0
Amortization of investment discounts (64) (1,085)
Stock-based compensation 4,830 4,942
Deferred income taxes (8,081) (1,366)
Loss from disposal of assets 23 0
Impairments 77,221 0
Currency translation adjustments (28) (125)
(Increase) decrease in    
Accounts receivable (5,644) 57
Prepaid income taxes 1,243 (398)
Prepaid expenses and other assets 274 (1,498)
Increase (decrease) in    
Accounts payable 1,061 514
Other liabilities (2,600) (22)
Deferred revenue 2,348 (1,663)
Net cash provided by operating activities 12,539 11,656
Cash flows from investing activities    
Purchases of property and equipment (449) (550)
Purchase of short-term investments (6,500) (67,159)
Proceeds from maturities of short-term investments 14,017 71,093
Proceeds from sales of investments 995 45,177
Purchase of long-term investments 0 0
Purchased intangibles (368) (508)
Net working capital & excess cash settlement - Pro-ficiency acquisition (227) 0
Capitalized computer software development costs (2,115) (2,520)
Net cash used in investing activities 5,353 45,533
Cash flows from financing activities    
Payment of dividends 0 (3,594)
Payments on contracts payable (1,576) (2,500)
Proceeds from the exercise of stock options 323 474
Net cash used in financing activities (1,253) (5,620)
Net increase in cash and cash equivalents 16,639 51,569
Cash and cash equivalents, beginning of period 10,311 57,523
Cash and cash equivalents, end of period 26,950 109,092
Supplemental disclosures of cash flow information    
Income taxes paid 1,020 4,214
Supplemental disclosures of non-cash activities    
Measurement period adjustments $ 956 $ 0